Terry Hexum, Ph.D - Publications

Affiliations: 
Pharmacology & Experimental Neuroscience University of Nebraska Medical Center, Omaha, NE, United States 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Luke TM, Hexum TD. UTP and ATP increase extracellular signal-regulated kinase 1/2 phosphorylation in bovine chromaffin cells through epidermal growth factor receptor transactivation. Purinergic Signalling. 4: 323-30. PMID 18777108 DOI: 10.1007/S11302-008-9098-Y  0.632
2008 Luke TM, Hexum TD. Tyrosine hydroxylase phosphorylation increases in response to ATP and neuropeptide Y co-stimulation of ERK2 phosphorylation. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 58: 52-7. PMID 18639636 DOI: 10.1016/J.Phrs.2008.06.010  0.624
2008 Huang Y, Erdmann N, Hexum TD, Zheng J. Cytokines and chemokines Neuroimmune Pharmacology. 183-205. DOI: 10.1007/978-0-387-72573-4_15  0.564
2007 Erdmann N, Zhao J, Lopez AL, Herek S, Curthoys N, Hexum TD, Tsukamoto T, Ferraris D, Zheng J. Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase. Journal of Neurochemistry. 102: 539-49. PMID 17596215 DOI: 10.1111/J.1471-4159.2007.04594.X  0.589
2004 Li X, Ikezu T, Hexum TD. Betagamma subunits mediate the NPY enhancement of ATP-stimulated inositol phosphate formation. Peptides. 25: 267-74. PMID 15063008 DOI: 10.1016/J.Peptides.2003.12.019  0.333
2003 Drakulich DA, Walls AM, Toews ML, Hexum TD. Neuropeptide Y receptor-mediated sensitization of ATP-stimulated inositol phosphate formation. The Journal of Pharmacology and Experimental Therapeutics. 307: 559-65. PMID 12970392 DOI: 10.1124/Jpet.103.053082  0.383
2001 Zhang P, Zheng J, Bradley ME, Hexum TD. ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y. Peptides. 22: 439-44. PMID 11287099 DOI: 10.1016/S0196-9781(01)00354-0  0.534
2000 Zheng J, Zhou G, Hexum TD. Neuropeptide Y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation. Life Sciences. 67: 617-25. PMID 12659167 DOI: 10.1016/S0024-3205(00)00666-4  0.517
2000 Zhang P, Zheng J, Vorce RL, Hexum TD. Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells. Regulatory Peptides. 87: 9-13. PMID 10710282 DOI: 10.1016/S0167-0115(99)00093-2  0.497
1998 Zhang P, Zheng J, Hexum TD. BIBP 3226 inhibition of nicotinic receptor mediated chromaffin cell secretion. European Journal of Pharmacology. 362: 121-5. PMID 9874161 DOI: 10.1016/S0014-2999(98)00729-8  0.519
1997 Zheng J, Zhang P, Hexum TD. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process. Molecular Pharmacology. 52: 1027-33. PMID 9415712 DOI: 10.1124/Mol.52.6.1027  0.54
1997 Zheng J, Zhang P, Toews M, Hexum TD. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells. Biochemical and Biophysical Research Communications. 239: 287-90. PMID 9345312 DOI: 10.1006/Bbrc.1997.7456  0.541
1989 Hexum TD, Russett LR. Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y. Neuropeptides. 13: 35-41. PMID 2922105 DOI: 10.1016/0143-4179(89)90019-X  0.308
Show low-probability matches.